This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Intracellular receptors
From Proteopedia
(Difference between revisions)
| Line 32: | Line 32: | ||
Negatively charged residues: E357, D384, E395, E399, E406, and E439 (red); | Negatively charged residues: E357, D384, E395, E399, E406, and E439 (red); | ||
Positively charged residues: R353, K361, R398, K410, K422, R426, R431, and K436 (blue); | Positively charged residues: R353, K361, R398, K410, K422, R426, R431, and K436 (blue); | ||
| - | Hydrophilic residues: S432 (green). | + | Hydrophilic residues: S432 (green). |
| + | |||
| + | Upon binding of the ligand ATRA in the cytoplasm, RARα and RXRα form a heterodimer and alter the C-terminals on domain H12 of both subunits in a manner that allows them to change the conformation of their DNA binding domains. The two proteins have 29% identity in their <scene name='RA_Mediated_T-reg_Differentiaition/Ligand_binding_pockets/1'>LBD</scene>. | ||
| + | For the ligand used in RARα crystallization, BMS614, 21 primarily hydrophobic residues form the <scene name='RA_Mediated_T-reg_Differentiaition/Rar-ligand_binding_pocket/1'>RAR-alpha ligand binding pocket</scene>. BMS614 is not the natural ligand for this molecule, but acts as an more stable agonist for crystallization. The largest difference between BMS614 and ATRA upon binding to the pocket are at Ile 412, where BMS614 pushes much closer to the amino acid than ATRA does. Residues that form the binding pocket are found on H1, H3, H5, H11, L6-7, and L11-12 on RARα. | ||
| + | The <scene name='RA_Mediated_T-reg_Differentiaition/Rar-ligand_binding_pocket2/1'>major differences</scene> between RARα, RARβ and RARγ are present in this area: | ||
| + | Residue 270: α:Ile β:Ile γ:Met; Residue 232: α:Ser β:Ala γ:Ala; Residue 395: α:Val β:Val γ:Ala | ||
| + | |||
| + | The <scene name='RA_Mediated_T-reg_Differentiaition/Rxr-ligand_binding_pocket/1'>RXR-alpha binding pocket</scene> is comprised of 16 primarily hydrophobic residues, found on the H3, H5, H7, H11, and L11-12 domains. The ligand used in the crystal, Oleic Acid, is similar to RA, and RA is capable of binding to the RXRα pocket. | ||
* [[PPAR-gamma]] | * [[PPAR-gamma]] | ||
* [[Pioglitazone]] is a selective agonist for Peroxisome Proliferator-Activated Receptor Gamma | * [[Pioglitazone]] is a selective agonist for Peroxisome Proliferator-Activated Receptor Gamma | ||
Revision as of 11:44, 19 May 2021
| |||||||||||
References
- ↑ Li MJ, Greenblatt HM, Dym O, Albeck S, Pais A, Gunanathan C, Milstein D, Degani H, Sussman JL. Structure of estradiol metal chelate and estrogen receptor complex: The basis for designing a new class of selective estrogen receptor modulators. J Med Chem. 2011 Apr 7. PMID:21473635 doi:10.1021/jm200192y
